Sub-pathway distribution of universally upregulated metabolites in all tumor groups. Supplementing Fig. 1d, this figure shows the sub metabolic pathways of universally upregulated metabolites in all tumor groups compared to normal mammary tissue. X-axis indicates percentage of all metabolites detected in each sub pathway that is upregulated, while y-axis indicates the sub pathways. (PPTX 361 kb
A list of targeted lipid metabolites in this study. The lipid metabolites targeted in this study wer...
Supporting information for delineation of CYP epoxygenase-associated networks as theranostic targets...
Tumor vs Normal 415-gene signature KEGG pathways. Full results of the KEGG human pathway enrichment ...
List of greatly upregulated metabolites in tumors. Related to Figs. 1 and 2. Metabolites that are si...
Raw data for CZE-MS/MS and list of significantly different metabolites from epithelial cells to adip...
Raw data for GC/LC-MS/MS metabolomics. Related to Figs. 1 and 2. This table contains all the GC/LC-...
List of model specific metabolites. Related to Fig. 2. Model specific metabolites were determined b...
Mouse models used in the study. Related to Fig. 1. This table includes the mouse models and the num...
Raw Data for Patient Survival Prediction Using Model Specific Metabolites. Related to Table 1. Usin...
Supplemental Figure 4. Metabolic pathway reconstructed from the metabolic data for colon and ovarian...
Table S3. Breast Cancer Data pathway analysis results of metabolites. Ingenuity Pathway Analysis Can...
Gene expression analysis of transgenic mouse models. Using previously published gene expression data...
Table S1. Publicly available resources utilized to download and process relevant data for multi-omic...
Figure S2. Preliminary analysis of filtered breast cancer data involving 108 samples (61 tumor and 4...
The Cancer Genome Atlas (TCGA) Ingenuity pathway analysis (IPA) upstream regulators. Table S1., Tabl...
A list of targeted lipid metabolites in this study. The lipid metabolites targeted in this study wer...
Supporting information for delineation of CYP epoxygenase-associated networks as theranostic targets...
Tumor vs Normal 415-gene signature KEGG pathways. Full results of the KEGG human pathway enrichment ...
List of greatly upregulated metabolites in tumors. Related to Figs. 1 and 2. Metabolites that are si...
Raw data for CZE-MS/MS and list of significantly different metabolites from epithelial cells to adip...
Raw data for GC/LC-MS/MS metabolomics. Related to Figs. 1 and 2. This table contains all the GC/LC-...
List of model specific metabolites. Related to Fig. 2. Model specific metabolites were determined b...
Mouse models used in the study. Related to Fig. 1. This table includes the mouse models and the num...
Raw Data for Patient Survival Prediction Using Model Specific Metabolites. Related to Table 1. Usin...
Supplemental Figure 4. Metabolic pathway reconstructed from the metabolic data for colon and ovarian...
Table S3. Breast Cancer Data pathway analysis results of metabolites. Ingenuity Pathway Analysis Can...
Gene expression analysis of transgenic mouse models. Using previously published gene expression data...
Table S1. Publicly available resources utilized to download and process relevant data for multi-omic...
Figure S2. Preliminary analysis of filtered breast cancer data involving 108 samples (61 tumor and 4...
The Cancer Genome Atlas (TCGA) Ingenuity pathway analysis (IPA) upstream regulators. Table S1., Tabl...
A list of targeted lipid metabolites in this study. The lipid metabolites targeted in this study wer...
Supporting information for delineation of CYP epoxygenase-associated networks as theranostic targets...
Tumor vs Normal 415-gene signature KEGG pathways. Full results of the KEGG human pathway enrichment ...